Patient Access Programs /Pharmaceutical Company Assistance

ABBVIE CARE With the approval of HOLKIRA PAK™, AbbVie is launching AbbVie Care, which is a program that will provide best-in-class solutions to improve outcomes for people living with hepatitis C. Canadians prescribed HOLKIRA PAK™ will have the opportunity to request to be enrolled in AbbVie Care. The signature care program is designed to provide a wide range of customized services including reimbursement assistance, education and ongoing disease manag

Tampa Bay woman with Hepatitis C reduces co-pay for treatments with coupon

PASADENA, FL (WFLA) — The FDA has approved several new cures for people fighting chronic diseases, but the problem is, many people can’t afford the drugs and insurance companies will cover only the sickest patients. That includes a drug now on the market for people with Hepatitis C called Harvoni — a pill that patients take for 8 to 12 weeks. Wendy Latorre, of Pasadena, says when she heard about the drugs she was extremely hopeful. “And then I found ou

Pre-Treatment Questions

Pre-Treatment Questions So many questions! Where to begin…?         Should I get treatment for HCV? Now? Later? Standard of Care or a Clinical Trial? How will I pay for it? Will I have to quit my job? Will my personality change?  What effect will it have on my family life? And that’s just the beginning!  It’s natural to have lots of questions, and smart to ask.  Don’t be shy.   This guide by Luci...